NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)

$0.5315 -0.0555 (-9.4549%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 78

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) News Sources

NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements

03-04-2026

yahoo.com

external link

NeuroSense Granted Brazilian Patent Covering PrimeC Composition

06-04-2026

yahoo.com

external link

NeuroSense Announces Pricing of Insider-Led PIPE Financing

28-04-2026

yahoo.com

external link

NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition

09-06-2026

yahoo.com

external link

NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS

11-06-2026

yahoo.com

external link

EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots

22-06-2026

yahoo.com

external link

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

25-06-2026

yahoo.com

external link

NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS

29-06-2026

yahoo.com

external link

NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"

06-07-2026

yahoo.com

external link

NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS

22-07-2026

yahoo.com

external link

NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) Sentiment Trend

0 25 50 75 100 59 69 86 79 76 90 83 86 88 66 03-04-2026 06-04-2026 28-04-2026 09-06-2026 11-06-2026 22-06-2026 25-06-2026 29-06-2026 06-07-2026 22-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) FAQs

toggle

What is the current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?

The current price of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is $0.5315.


toggle

NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) absolute price change since previous trading day?

The absolute price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is $-0.0555.


toggle

NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) percentage price change since previous trading day?

The percentage price change of NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) since the previous trading day is -9.4549%.


toggle

What is the most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?

The most recent average sentiment score for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is 78 out of 100.


toggle

What is the most recent average sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)?

The most recent sentiment for NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ) is .


SEC-8K** Filing Available For NEUROSENSE THERAPEUTICS LTD (NRSN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

NRSNW (Neurosense Therapeutics Ltd WT)
NGNE (Neurogene Inc)
NMTC (Neuroone Medical Technologies Corp)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.